Figure 1.
Figure 1. ABCG2 expression and function in myeloma cell lines. (A) Flow cytometric analysis of MM cell lines for ABCG2 membrane expression was performed. 8226MR cells express more ABCG2 than wild-type 8226 cells, and H929 cells express very little, as shown by the shift in fluorescence. (B) Immunostaining of myeloma cell lines using an anti-ABCG2 FITC (Chemicon)–labeled antibody (ABCG2 is green and DAPI is blue). (C) Western blot of protein (25 μg/lane) extracted from myeloma cell lines for ABCG2. (D) Functional analysis of ABCG2 using topotecan as a substrate and the ABCG2-specific inhibitor tryprostatin A. Topotecan, a very good ABCG2 substrate and a naturally fluorescent molecule, is effluxed in high (8226MR) and moderate (8226) ABCG2 expressers, but is accumulated by H929 cells (which do not express ABCG2). Tryprostatin A (trypA) blocks the efflux of topotecan, demonstrating that topotecan efflux is ABCG2 dependent.

ABCG2 expression and function in myeloma cell lines. (A) Flow cytometric analysis of MM cell lines for ABCG2 membrane expression was performed. 8226MR cells express more ABCG2 than wild-type 8226 cells, and H929 cells express very little, as shown by the shift in fluorescence. (B) Immunostaining of myeloma cell lines using an anti-ABCG2 FITC (Chemicon)–labeled antibody (ABCG2 is green and DAPI is blue). (C) Western blot of protein (25 μg/lane) extracted from myeloma cell lines for ABCG2. (D) Functional analysis of ABCG2 using topotecan as a substrate and the ABCG2-specific inhibitor tryprostatin A. Topotecan, a very good ABCG2 substrate and a naturally fluorescent molecule, is effluxed in high (8226MR) and moderate (8226) ABCG2 expressers, but is accumulated by H929 cells (which do not express ABCG2). Tryprostatin A (trypA) blocks the efflux of topotecan, demonstrating that topotecan efflux is ABCG2 dependent.

Close Modal

or Create an Account

Close Modal
Close Modal